This report provides exclusive insights into the COVID-19 impact on the Anatomic Pathology Testing Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Anatomic Pathology Testing Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Anatomic Pathology Testing Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on
anatomic pathology testing market provides an in-depth analysis of segments and
sub-segments in global as well as regional anatomic pathology testing market.
The study also highlights the impact of drivers, restraints and macro
indicators on the global and regional anatomic pathology testing market over
the short term as well as long term. The report is a comprehensive presentation
of trends, forecast and dollar values of global anatomic pathology testing
market. According to the report the global anatomic pathology testing market is
projected to grow at a CAGR of 5.3% over the forecast period of 2018-2024.
Anatomical/Anatomic pathology is
a medical sphere that is related to the diagnosis of disease based on the
macroscopic, microscopic, biochemical, immunologic and molecular examination of
organs and tissues. Anatomic pathology testing deals with diagnosing disease by
examining tissues, either through gross pathology or by light microscopy and
other advanced techniques.
The increasing prevalence of
chronic diseases, changing lifestyle, growing the aging population, modernization
of medical facilities, development of medical science and increasing healthcare
expenditure are the major factors driving the growth of this market. Increasing
R&D expenditure is driving the adoption of anatomic pathology services in
pharmaceutical and biopharmaceutical companies for drug discovery &
On the basis of region, the
anatomic pathology testing market is divided into North America, Europe, Asia, and the
Rest of the World (RoW).North America held the largest market share in 2017 on the account of the increasing demand for medical facilities, increasing healthcare spending
and government initiatives, rising awareness about the use of anatomic
pathology tests among physicians or doctors are some major factors driving the
growth of this regional segment. Asia- Pacific region is expected to grow at the
highest CAGR during the forecast period.
The report on global anatomic pathology testing market covers
segments such as component, application, and region. On the basis of component the global anatomic
pathology testing market is categorized into instruments, consumables, and
services. On the basis of application the global anatomic pathology testing
market is categorized into disease diagnosis, drug discovery & development, and other applications. On the basis of region, the global anatomic pathology
testing market is categorized into North America, Europe, Asia-Pacific and rest
of the world (RoW).
The report provides regional analysis covering geographies such
as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography are provided over the period
of 2016-2024. The countries covered in the North America region include the
U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India,
South Korea, Malaysia, and among others. Moreover, Germany, U.K., France,
Spain and Rest of Europe are included in the European region. The U.S. drives
the growth in the North America region as it is the largest market in the
region. The Asia-Pacific region offers a substantial potential for the market
growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a
growth at a CAGR of x.x% over the period of 2018-2024.
The report provides profiles of the companies in the global
anatomic pathology testing market such as Sakura Finetechnical Co., Ltd.
(Japan), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of
America Holdings (U.S.), NeoGenomics Laboratories, Inc. (U.S.)., Agilent
Technologies (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific
(U.S.), F. Hoffmann-La Roche AG (Switzerland), Abbott Diagnostics and
Advanced Cell Diagnostics.
The report provides deep insights on demand forecasts, market
trends, and micro and macro indicators. In addition, this report provides
insights into the factors that are driving and restraining the global anatomic
pathology testing market. Moreover, IGR-Growth Matrix analysis given in the
report brings an insight into the investment areas that existing or new market
players can consider. The report provides insights into the market using
analytical tools such as Porter's five forces analysis and DRO analysis of
anatomic pathology testing market. Moreover, the study highlights current
market trends and provides forecast from 2018-2024. We also have highlighted
future trends in the anatomic pathology testing market that will impact the
demand during the forecast period. Moreover, the competitive analysis given in
each regional market brings an insight into the market share of the leading
players. This report will help manufacturers, suppliers, and distributors of the
anatomic pathology testing market to understand the present and future trends
in this market and formulate their strategies accordingly.